Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays

ConclusionsCommercial assays for pepsinogen have good relative agreement but are imperfect tests for clinical diagnosis of gastric atrophy.
ImpactPepsinogen testing alone does not provide sufficient information for gastric cancer risk stratification. Future investigations should focus on other potential markers, in combination with pepsinogens.

Source: Helicobacter - May 30, 2017 Category: Gastroenterology Authors: Marcis Leja, Maria C. Camargo, Inese Polaka, Sergejs Isajevs, Inta Liepniece ‐Karele, Dainius Janciauskas, Dace Rudzite, Ilze Kikuste, Aigars Vanags, Ilona Kojalo, Valdis Folkmanis, Arnis Kirsners, Ivars Tolmanis, Charles S. Rabkin Tags: ORIGINAL ARTICLE Source Type: research